Definitive Healthcare Corp. (DH): Price and Financial Metrics


Definitive Healthcare Corp. (DH): $16.69

0.04 (+0.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

DH Stock Price Chart Interactive Chart >

Price chart for DH

DH Price/Volume Stats

Current price $16.69 52-week high $50.30
Prev. close $16.65 52-week low $14.76
Day low $16.41 Volume 489,800
Day high $17.43 Avg. volume 615,597
50-day MA $22.78 Dividend yield N/A
200-day MA $0.00 Market Cap 1.63B

Definitive Healthcare Corp. (DH) Company Bio


Definitive Healthcare Corp., through its subsidiaries, provides healthcare commercial intelligence. It offers information on healthcare providers and their activities to help its customers optimize everything from product development to go-to-market planning and sales and marketing execution. The company's platform currently offers 13 intelligence modules. It serves life sciences companies, healthcare information technology companies, healthcare providers, and other diversified companies. The company was founded in 2011 and is based in Framingham, Massachusetts.


DH Latest News Stream


Event/Time News Detail
Loading, please wait...

DH Latest Social Stream


Loading social stream, please wait...

View Full DH Social Stream

Latest DH News From Around the Web

Below are the latest news stories about Definitive Healthcare Corp that investors may wish to consider to help them evaluate DH as an investment opportunity.

Definitive Healthcare Corp.'s (DH) CEO Jason Krantz on Q4 2021 Results - Earnings Call Transcript

Definitive Healthcare Corp. (DH) Q4 2021 Earnings Conference Call February 23, 2022, 05:00 PM ET Company Participants David Samuels - General Counsel & Chief Legal Officer Jason Krantz - Founder and CEO Rick Booth - Chief Financial Officer Robert Musslewhite - President Conference Call Participants Craig Hettenbach - Morgan Stanley...

SA Transcripts on Seeking Alpha | February 24, 2022

Definitive Healthcare Corp. 2021 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Definitive Healthcare Corp. in conjunction with their 2021 Q4 earnings call....

SA Transcripts on Seeking Alpha | February 23, 2022

Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Year Fiscal 2021

Fourth quarter revenue grew 38% year-over-year to $46.3 millionFull year 2021 revenue grew 40% to $166.2 million FRAMINGHAM, Mass., Feb. 23, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced financial results for the quarter and full year ended December 31, 2021. Fourth Quarter 2021 Financial Highlights: Revenue was $46.3 million, an increase of 38% from $33.7 million in Q4 2020.

Yahoo | February 23, 2022

Jefferies Remains a Buy on Definitive Healthcare Corp (DH)

In a report released today, Glen Santangelo from Jefferies reiterated a Buy rating on Definitive Healthcare Corp (DH – Research Report), with a price target of $36.00. The company's shares closed last Monday at $23.54. According to TipRanks.com, Santangelo is a 5-star analyst with an average return of 21.2% and a 67.6% success rate. Santangelo covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, Hims & Hers Health, and Health Catalyst. Currently, the analyst consensus on Definitive Healthcare Corp is a Moderate Buy with an average price target of $33.83.

Catie Powers on TipRanks | February 15, 2022

Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2021 Financial Results Conference Call and Webcast

FRAMINGHAM, Mass., Jan. 31, 2022 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ: DH ), an industry leader in healthcare commercial intelligence, today announced that its fourth quarter and full year ended December 31, 2021 financial results will be released on Wednesday, February 23, 2022, after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss … Full story available on Benzinga.com

Benzinga | January 31, 2022

Read More 'DH' Stories Here

DH Price Returns

1-mo -30.57%
3-mo -27.78%
6-mo -51.99%
1-year N/A
3-year N/A
5-year N/A
YTD -38.93%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7105 seconds.